Jefferies Group LLC Boosts PAREXEL International Corporation (PRXL) Price Target to $67.00

Jefferies Group LLC Boosts PAREXEL International Corporation (PRXL) Price Target to $67.00

PAREXEL International Corporation (NASDAQ:PRXL) had its target price hoisted by Jefferies Group LLC from $64.00 to $67.00 in a report issued on Tuesday. Jefferies Group LLC currently has a hold rating on the stock.

PRXL has been the topic of a number of other research reports. Credit Suisse Group reissued a buy rating on shares of PAREXEL International Corporation in a research note on Tuesday, September 27th. Zacks Investment Research raised PAREXEL International Corporation from a sell rating to a hold rating in a research note on Wednesday, October 19th. Robert W. Baird cut PAREXEL International Corporation from an outperform rating to a neutral rating and dropped their price target for the stock from $78.00 to $67.00 in a research note on Thursday, October 27th. Deutsche Bank AG dropped their price target on PAREXEL International Corporation from $71.00 to $65.00 and set a hold rating on the stock in a research note on Friday, October 28th. Finally, Evercore ISI reissued a buy rating and issued a $70.00 price target (down previously from $79.00) on shares of PAREXEL International Corporation in a research note on Saturday, October 29th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company’s stock. PAREXEL International Corporation has a consensus rating of Hold and an average target price of $67.55.

PAREXEL International Corporation (NASDAQ:PRXL) traded down 0.14% on Tuesday, reaching $70.09. 206,241 shares of the company traded hands. The stock has a market capitalization of $3.73 billion, a price-to-earnings ratio of 22.46 and a beta of 0.89. PAREXEL International Corporation has a 52-week low of $51.16 and a 52-week high of $72.32. The firm has a 50 day moving average price of $67.24 and a 200 day moving average price of $65.69.

PAREXEL International Corporation (NASDAQ:PRXL) last released its earnings results on Wednesday, October 26th. The company reported $0.76 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.86 by $0.10. The firm had revenue of $500.90 million for the quarter, compared to analyst estimates of $525.15 million. PAREXEL International Corporation had a return on equity of 30.71% and a net margin of 7.09%. PAREXEL International Corporation’s revenue was down 2.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.70 earnings per share. Equities research analysts predict that PAREXEL International Corporation will post $3.75 EPS for the current year.

Several large investors have recently made changes to their positions in the stock. MSI Financial Services Inc raised its stake in shares of PAREXEL International Corporation by 17.4% in the third quarter. MSI Financial Services Inc now owns 1,690 shares of the company’s stock valued at $117,000 after buying an additional 250 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of PAREXEL International Corporation by 13.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,806 shares of the company’s stock valued at $125,000 after buying an additional 213 shares in the last quarter. Robecosam AG raised its stake in shares of PAREXEL International Corporation by 40.1% in the second quarter. Robecosam AG now owns 2,200 shares of the company’s stock valued at $132,000 after buying an additional 630 shares in the last quarter. Quantbot Technologies LP raised its stake in shares of PAREXEL International Corporation by 22.7% in the third quarter. Quantbot Technologies LP now owns 2,000 shares of the company’s stock valued at $138,000 after buying an additional 370 shares in the last quarter. Finally, Paradigm Asset Management Co. LLC raised its stake in shares of PAREXEL International Corporation by 683.3% in the second quarter. Paradigm Asset Management Co. LLC now owns 2,350 shares of the company’s stock valued at $148,000 after buying an additional 2,050 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

About PAREXEL International Corporation

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

Related posts

Leave a Comment